| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,104 |
11,274 |
$442K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
4,037 |
3,307 |
$386K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,175 |
3,476 |
$189K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,820 |
3,075 |
$151K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,345 |
1,180 |
$114K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,814 |
1,924 |
$86K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,462 |
1,272 |
$61K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
733 |
647 |
$33K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
353 |
316 |
$16K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
349 |
277 |
$14K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
253 |
226 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
952 |
465 |
$10K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
288 |
252 |
$10K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,223 |
954 |
$9K |
| 80053 |
Comprehensive metabolic panel |
746 |
696 |
$8K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
724 |
554 |
$7K |
| 87428 |
|
89 |
83 |
$6K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
121 |
91 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
397 |
375 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
311 |
270 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
236 |
210 |
$4K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
99 |
94 |
$3K |
| 84480 |
|
189 |
167 |
$3K |
| T1502 |
Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit |
1,579 |
1,364 |
$2K |
| 84439 |
|
208 |
184 |
$2K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
994 |
853 |
$2K |
| 90686 |
|
255 |
203 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
118 |
101 |
$2K |
| 90633 |
|
146 |
132 |
$1K |
| 74018 |
|
60 |
56 |
$1K |
| 80061 |
Lipid panel |
100 |
90 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
741 |
617 |
$996.21 |
| 90734 |
|
94 |
82 |
$745.68 |
| 90649 |
|
69 |
65 |
$652.40 |
| 90670 |
|
86 |
69 |
$630.96 |
| 81003 |
|
1,064 |
842 |
$607.57 |
| 90619 |
|
49 |
44 |
$538.74 |
| 90647 |
|
65 |
56 |
$516.24 |
| 90710 |
|
61 |
53 |
$468.44 |
| 90715 |
|
49 |
43 |
$434.92 |
| 90723 |
|
50 |
41 |
$363.28 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,392 |
1,201 |
$314.74 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
175 |
149 |
$294.58 |
| 82962 |
|
88 |
79 |
$240.12 |
| 71045 |
Radiologic examination, chest; single view |
22 |
18 |
$237.20 |
| 90648 |
|
12 |
12 |
$185.40 |
| 87807 |
|
15 |
14 |
$169.13 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
17 |
15 |
$166.44 |
| 90696 |
|
13 |
12 |
$105.16 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
17 |
17 |
$36.18 |
| 3078F |
|
1,653 |
1,407 |
$0.00 |
| 3077F |
|
105 |
93 |
$0.00 |
| 3079F |
|
406 |
372 |
$0.00 |
| 3075F |
|
178 |
156 |
$0.00 |
| 3080F |
|
44 |
41 |
$0.00 |
| 3074F |
|
1,830 |
1,566 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
632 |
278 |
$0.00 |